Enhancer remodeling regulates epigenetic adaptation and resistance to MEK1/2 inhibition in triple-negative breast cancer by Samantha M. Bevill, Jon S. Zawistowski, Gary L. Johnson

Get full text

Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition by Evan DuBose, Evan DuBose, Samantha M. Bevill, Samantha M. Bevill, Dana K. Mitchell, Noah Sciaky, Brian T. Golitz, Shelley A. H. Dixon, Steven D. Rhodes, Steven D. Rhodes, Steven D. Rhodes, Steven D. Rhodes, James E. Bear, James E. Bear, James E. Bear, Gary L. Johnson, Gary L. Johnson, Steven P. Angus, Steven P. Angus, Steven P. Angus, Steven P. Angus, Steven P. Angus

Get full text

Chromatin complex dependencies reveal targeting opportunities in leukemia by Fadi J. Najm, Peter DeWeirdt, Molly M. Moore, Samantha M. Bevill, Chadi A. El Farran, Kevin A. Macias, Mudra Hegde, Amanda L. Waterbury, Brian B. Liau, Peter van Galen, John G. Doench, Bradley E. Bernstein

Get full text

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036 by Steven P. Angus, Timothy J. Stuhlmiller, Gaurav Mehta, Samantha M. Bevill, Daniel R. Goulet, J. Felix Olivares-Quintero, Michael P. East, Maki Tanioka, Jon S. Zawistowski, Darshan Singh, Noah Sciaky, Xin Chen, Xiaping He, Naim U. Rashid, Lynn Chollet-Hinton, Cheng Fan, Matthew G. Soloway, Patricia A. Spears, Stuart Jefferys, Joel S. Parker, Kristalyn K. Gallagher, Andres Forero-Torres, Ian E. Krop, Alastair M. Thompson, Rashmi Murthy, Michael L. Gatza, Charles M. Perou, H. Shelton Earp, Lisa A. Carey, Gary L. Johnson

Get full text